Influenza and pneumococcal vaccination as a model to assess C-reactive protein response to mild inflammation
- 12 July 2004
- Vol. 23 (3) , 362-365
- https://doi.org/10.1016/j.vaccine.2004.05.035
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Inflammatory bio‐markers and cardiovascular risk predictionJournal of Internal Medicine, 2002
- Yellow fever vaccination as a model to study the response to stimulation of the inflammation systemVascular Pharmacology, 2002
- Prevention of Inflammation-Induced Endothelial DysfunctionCirculation, 2002
- Cytokines in the Pathogenesis of AtherosclerosisThrombosis and Haemostasis, 2002
- Unstable Angina and Elevated C-Reactive Protein Levels Predict Enhanced Vasoreactivity of the Culprit LesionCirculation, 2001
- Generation of C-Reactive Protein and Complement Components in Atherosclerotic PlaquesPublished by Elsevier ,2001
- Acute Systemic Inflammation Impairs Endothelium-Dependent Dilatation in HumansCirculation, 2000
- C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged MenCirculation, 1999
- Intense acute phase response in ischemic patientsInternational Journal of Cardiology, 1999
- Plasma Concentration of C-Reactive Protein and Risk of Developing Peripheral Vascular DiseaseCirculation, 1998